| Q36685008 | A Case of Neuro-Behcet's Disease Presenting with Central Neurogenic Hyperventilation |
| Q42363486 | A Rare Case of Unilateral Progressive Vision Loss and Pachymeningitis |
| Q58767210 | A challenging case of tuberculosis-associated uveitis after corticosteroid treatment for Vogt-Koyanagi-Harada disease |
| Q53060098 | A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease. |
| Q36528755 | Acute myelitis in a patient with vogt-koyanagi-harada disease: case report and review of the literature. |
| Q42027806 | Alterations of color vision and central visual field in patients with Vogt-Koyanagi-Harada syndrome |
| Q86695073 | Analysis of choroidal folds in acute Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography |
| Q39687072 | Angiographic and spectral domain optical coherence tomography features in case of Vogt-Koyanagi-Harada disease |
| Q45944918 | Anterior ischemic optic neuropathy associated with Vogt-Koyanagi-Harada disease. |
| Q46459814 | Anterior segment optical coherence tomography findings of acute angle-closure glaucoma in Vogt-Koyanagi-Harada disease |
| Q34477842 | Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: a systematic review and meta-analysis |
| Q36893486 | Association of Vogt Koyanagi Harada Syndrome and Seronegative Rheumatoid Arthritis. |
| Q50003219 | Association of human leukocyte antigen (HLA)-DQ and HLA-DQA1/DQB1 alleles with Vogt-Koyanagi-Harada disease: A systematic review and meta-analysis |
| Q57055880 | Autoimmune vertigo: an update on vestibular disorders associated with autoimmune mechanisms |
| Q64970275 | Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt-Koyanagi-Harada Disease: A Multimodal Imaging Follow-Up Study. |
| Q73015410 | Behçet's disease |
| Q26749730 | Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment |
| Q28080595 | Birdshot retinochoroidopathy |
| Q30469260 | CNS diseases and uveitis |
| Q89285637 | Catching the therapeutic window of opportunity in early initial-onset Vogt-Koyanagi-Harada uveitis can cure the disease |
| Q39192598 | Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases. |
| Q40949447 | Changing patterns in uveitis of childhood |
| Q39053494 | Choroidal atrophy and loss of choriocapillaris in convalescent stage of Vogt-Koyanagi-Harada disease: in vivo documentation |
| Q42162374 | Choroidal dye filling velocity in patients with Vogt-Koyanagi-Harada disease |
| Q50504474 | Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. |
| Q50278316 | Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment |
| Q41405377 | Clinical spectrum and management options in Vogt-Koyanagi-Harada disease |
| Q36342993 | Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy |
| Q33904800 | Comparison of the optical coherence tomographic characters between acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy |
| Q43597449 | Complications and prognostic factors in Vogt-Koyanagi-Harada disease |
| Q91977864 | Concurrent presence of retinal hemorrhages in the setting of acute Vogt-Koyanagi-Harada syndrome - an unusual presentation |
| Q35422986 | Copy number variants and genetic polymorphisms in TBX21, GATA3, Rorc, Foxp3 and susceptibility to Behcet's disease and Vogt-Koyanagi-Harada syndrome |
| Q35947745 | Copy number variations and gene polymorphisms of complement components in ocular Behcet's disease and Vogt-Koyanagi-Harada syndrome |
| Q48600964 | Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease |
| Q33737954 | Current approach in the diagnosis and management of panuveitis |
| Q33517496 | Cyclophosphamide for ocular inflammatory diseases |
| Q35575081 | Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? |
| Q47115686 | Decision-making and management of uveitic cataract |
| Q35593900 | Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease |
| Q36542187 | Decreased B and T lymphocyte attenuator in Behcet's disease may trigger abnormal Th17 and Th1 immune responses |
| Q43597451 | Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease |
| Q33755275 | Determination of Genes Related to Uveitis by Utilization of the Random Walk with Restart Algorithm on a Protein-Protein Interaction Network |
| Q89440401 | Development and Evaluation of Diagnostic Criteria for Vogt-Koyanagi-Harada Disease |
| Q38281318 | Differences in the clinical features of two types of Vogt-Koyanagi-Harada disease: serous retinal detachment and optic disc swelling |
| Q33750289 | Disorders that mimic central nervous system infections |
| Q46680282 | Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease |
| Q83436273 | Evaluation of NLRP1 gene polymorphisms in Vogt-Koyanagi-Harada disease |
| Q37213674 | Evaluation of PTPN22 polymorphisms and Vogt-Koyanagi-Harada disease in Japanese patients. |
| Q35227675 | Exudative detachment as a masquerader in hypoalbuminaemic patients |
| Q80827503 | Eyelash poliosis in association with sarcoidosis |
| Q35884592 | Factors associated with optic nerve head blood flow and color tone: a retrospective observational study |
| Q79660669 | Fluorescein fundus angiographic findings in Vogt-Koyanagi-Harada syndrome |
| Q33805825 | Free radical mediated photoreceptor damage in uveitis |
| Q33695678 | Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease |
| Q33234061 | Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease |
| Q38542359 | Fundus autofluorescence applications in retinal imaging |
| Q37661279 | Gender differences in vogt-koyanagi-harada disease and sympathetic ophthalmia |
| Q87535357 | Genome-wide association analysis of Vogt-Koyanagi-Harada syndrome identifies two new susceptibility loci at 1p31.2 and 10q21.3. |
| Q41481097 | Glaucoma associated with uveitis |
| Q34274659 | Headache as an initial manifestation of Vogt-Koyanagi-Harada disease |
| Q34051879 | Headache, red eyes, blurred vision and hearing loss. Diagnosis: Vogt-Koyanagi-Harada syndrome |
| Q50436770 | Hearing loss, uveomeningitis, and stroke in a 55‐year‐old man |
| Q53637012 | High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids. |
| Q34460045 | Immunopathology of the noninfectious posterior and intermediate uveitides |
| Q41162044 | Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals |
| Q36802428 | Indocyanine green angiographic findings in Vogt-Koyanagi-Harada disease |
| Q42835965 | Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients |
| Q37023488 | Indocyanine green angiography in posterior uveitis |
| Q80258853 | Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease |
| Q33929571 | Influence of molecular genetics in Vogt-Koyanagi-Harada disease. |
| Q99409216 | Initial-onset acute and chronic recurrent stages are two distinctive courses of Vogt-Koyanagi-Harada disease |
| Q33823763 | Inner retinal changes in acute-phase Vogt-Koyanagi-Harada disease measured by enhanced spectral domain optical coherence tomography |
| Q35589983 | Iris nodules associated with infectious uveitis |
| Q39825616 | Juvenile Vogt-Koyanagi-Harada Disease in Which Good Visual Prognosis Was Derived from Swift and Definitive Diagnosis |
| Q92861110 | Long-term changes of retinal pigment epithelium in the eyes with Vogt-Koyanagi-Harada disease observed by adaptive optics imaging |
| Q48241790 | Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease |
| Q50506391 | Low-frequency masking for detection of endolymphatic hydrops in patients with glaucoma. |
| Q40176148 | Management of a rare presentation of Vogt-Koyanagi-Harada disease in human immunodeficiency virus/acquired immunodeficiency disease syndrome patient |
| Q41625926 | Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome |
| Q37294282 | Monocyte chemoattractant protein (MCP)-1 -2518 A/G SNP in Chinese Han patients with VKH syndrome |
| Q52887652 | Multi-modal imaging and anatomic classification of the white dot syndromes. |
| Q46357722 | Multifocal electroretinographic evaluation of macular function in acute posterior multifocal placoid pigment epitheliopathy |
| Q38171373 | Noninfectious immune-mediated uveitis and ocular inflammation |
| Q83072436 | Optical coherence tomographic assessment of dynamic macular changes in patients with Vogt-Koyanagi-Harada disease |
| Q92460478 | PRKCQ rs4750316 is associated with Vogt-Koyanagi-Harada syndrome in a Han Chinese population |
| Q36792615 | Pathology of Vogt-Koyanagi-Harada disease |
| Q46630364 | Peripheral iris depigmentation and ocular hypotony: result of the natural course of non-treated Vogt-Koyanagi-Harada (VKH) disease |
| Q42578943 | Poliosis of eyelashes as an unusual sign of a halo nevus |
| Q37194571 | Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome |
| Q36953242 | Posterior segment recurrences in Vogt-Koyanagi-Harada disease |
| Q80162168 | Prognostic factors in Vogt-Koyanagi-Harada disease |
| Q36174200 | Pseudotumoral and Multiple Retinal Pigment Epithelium Proliferation in Vogt-Koyanagi-Harada Disease. |
| Q39008824 | Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality. |
| Q49630678 | Recovery of macular cone photoreceptors in Vogt-Koyanagi-Harada disease |
| Q40235043 | Recurrent Vogt–Koyanagi–Harada disease with sensorineural hearing loss and choroidal thickening |
| Q53183977 | Relative changes in luminal and stromal areas of choroid determined by binarization of EDI-OCT images in eyes with Vogt-Koyanagi-Harada disease after treatment. |
| Q33989519 | Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings. |
| Q38059601 | Retinal pigment epithelium folds as a diagnostic finding of Vogt-Koyanagi-Harada disease |
| Q46756795 | Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature |
| Q44310003 | Rhegmatogenous retinal detachment and uveitis |
| Q50498947 | Role of S-100beta as potential autoantigen in an autoimmune disease of the inner ear. |
| Q37716091 | Role of autofluorescence in inflammatory/infective diseases of the retina and choroid. |
| Q74644028 | Serous detachment of the ciliary body in Harada disease |
| Q35763685 | Significant prognostic factors for Vogt-Koyanagi-Harada disease in the early stage |
| Q37034965 | Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population. |
| Q36653244 | Spectrum of Vogt-Koyanagi-Harada disease in Singapore |
| Q34018166 | Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease |
| Q38103179 | Syndromes of hearing loss associated with visual loss |
| Q34651381 | TNFAIP3 gene polymorphisms in a Chinese Han population with Vogt-Koyanagi-Harada syndrome |
| Q31813021 | The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease |
| Q50746452 | The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease. |
| Q35979092 | The eye in systemic inflammatory diseases |
| Q90290639 | The eyelash follicle features and anomalies: A review |
| Q35849200 | The role of sex in uveitis and ocular inflammation |
| Q39161846 | The spectrum of Vogt-Koyanagi-Harada disease in Iran. |
| Q51765305 | The spectrum of Vogt-Koyanagi-Harada disease in South India. |
| Q39130741 | The spectrum of Vogt-Koyanagi-Harada disease in Tunisia, North Africa |
| Q51787418 | The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey. |
| Q41667234 | Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease |
| Q45928295 | Trabecular meshwork depigmentation in Vogt-Koyanagi-Harada disease. |
| Q33237415 | Two cases of subretinal neovascular membrane in Vogt-Koyanagi-Harada syndrome |
| Q30542653 | Ultrasound biomicroscopic study of ciliary body changes in the post-treatment phase of Vogt-Koyanagi-Harada disease |
| Q52571477 | Unusual Case of Vogt-Koyanagi-Harada Disease Associated with SAPHO Syndrome: A Case Report. |
| Q40932784 | Unusual Case of Vogt-Koyanagi-Harada Syndrome Presenting as Non-specific Headache |
| Q57821296 | Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment |
| Q58694353 | Usefulness of B-scan ocular ultrasound images for diagnosis of optic perineuritis |
| Q46047813 | Utility of existing Vogt-Koyanagi-Harada syndrome diagnostic criteria at initial evaluation of the individual patient: a retrospective analysis |
| Q43465359 | Utility of lumbar puncture in diagnosis of Vogt-Koyanagi-Harada disease |
| Q37121919 | Uveitic foveal atrophy: clinical features and associations |
| Q46366395 | Viagra-associated serous macular detachment |
| Q46371615 | Visual function in Vogt-Koyanagi-Harada patients. |
| Q74561993 | Vitiligo |
| Q35565685 | Vitiligo and leukoderma in children |
| Q47555756 | Vogt-Koyanagi-Harada Disease Associated with Influenza A Virus Infection: A Case Report |
| Q64237145 | Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma |
| Q45159032 | Vogt-Koyanagi-Harada Disease: clinical features, therapy and long-term visual outcome in a Caucasian and African population |
| Q45218710 | Vogt-Koyanagi-Harada disease diagnostic criteria |
| Q36895013 | Vogt-Koyanagi-Harada disease following BCG vaccination and tuberculosis |
| Q36767557 | Vogt-Koyanagi-Harada disease in Hispanic patients |
| Q80265254 | Vogt-Koyanagi-Harada disease in children |
| Q80164684 | Vogt-Koyanagi-Harada disease in elderly Japanese patients |
| Q43153173 | Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection |
| Q35833086 | Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C. |
| Q48201490 | Vogt-Koyanagi-Harada disease presenting as optic neuritis |
| Q96955181 | Vogt-Koyanagi-Harada disease presenting secondary to a post-infectious Mycoplasma pneumoniae autoimmune response |
| Q42094902 | Vogt-Koyanagi-Harada disease-like posterior uveitis in the course of nivolumab (anti-PD-1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma. |
| Q26752297 | Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes |
| Q28072882 | Vogt-Koyanagi-Harada syndrome - current perspectives |
| Q74611002 | Vogt-Koyanagi-Harada syndrome after cutaneous injury |
| Q50233732 | Vogt-Koyanagi-Harada syndrome and Crohn's disease: an exceptional association |
| Q45988198 | Vogt-Koyanagi-Harada syndrome in a 4-year old child. |
| Q77454550 | Vogt-Koyanagi-Harada syndrome in children |
| Q73841508 | Vogt-Koyanagi-Harada syndrome presenting as a severe systemic illness |
| Q64042187 | Vogt-Koyanagi-Harada syndrome: a serious and rare emergency in children |
| Q53241866 | Vogt-koyanagi-harada disease with onset in elderly patients aged 68 to 89 years. |
| Q44656251 | Vogt–Koyanagi–Harada syndrome associated with cutaneous malignant melanoma: an 11-year follow-up |
| Q40972896 | Wide-field fluorescein and indocyanine green angiography findings in the eyes with Vogt-Koyanagi-Harada disease |
| Q40450685 | Work-up, diagnosis and management of acute Vogt-Koyanagi-Harada disease: a case of acute myopization with granulomatous uveitis. |
| Q50474235 | [Diagnostic and therapeutic management of Vogt-Koyanagi-Harada syndrome] |
| Q86725083 | [Long-term course of immunosuppressive therapy of Vogt-Koyanagi-Harada syndrome] |
| Q83857042 | [Sudden appearance and rapide progression of bilateral visual deterioration] |
| Q82757399 | [Trabeculectomy for the management of uveitic glaucoma] |
| Q50469411 | [Vogt-Koyanagi-Harada syndrome] |